Parenteral Drug Association
FDANonrulemakingFDA-2020-D-1294

Setting Endotoxin Limits During Development of Investigational Oncology Drugs and Biological Products; Draft Guidance for Industry; Availability

RIN
Last modified
Oct 29, 2020
Comment window
closed 2129d ago
Parenteral Drug Association filings
1

Activity

Parenteral Drug Association filed 1 comment on this docket between Oct 29, 2020 and Oct 29, 2020. 0 other organizations filed here. The comment window closed 2129d ago.

What Parenteral Drug Association filed (1)

Oct 29, 2020· Comment from Parenteral Drug Association· FDA-2020-D-1294-0010

Filed on regulations.gov — full text not in the inline record.

Abstract

No abstract recorded.

View on regulations.gov →
Setting Endotoxin Limits During Development of Investigational Oncology Drugs and Biological Products; Draft Guidance for Industry; Availability (FDA) — Parenteral Drug Association | OpenPolis